225 related articles for article (PubMed ID: 8606872)
1. Cell kinetic studies on prostatic intraepithelial neoplasia (PIN) and atypical adenomatous hyperplasia (AAH) of the prostate.
Helpap B
Pathol Res Pract; 1995 Sep; 191(9):904-7. PubMed ID: 8606872
[TBL] [Abstract][Full Text] [Related]
2. Nucleolar and AgNOR-analysis of prostatic intraepithelial neoplasia (PIN), atypical adenomatous hyperplasia (AAH) and prostatic carcinoma.
Helpap B; Riede C
Pathol Res Pract; 1995 Jun; 191(5):381-90. PubMed ID: 7479355
[TBL] [Abstract][Full Text] [Related]
3. Prospective origins of prostate carcinoma. Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia.
Bostwick DG
Cancer; 1996 Jul; 78(2):330-6. PubMed ID: 8674012
[TBL] [Abstract][Full Text] [Related]
4. The extent and zonal location of prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia: relationship with carcinoma in radical prostatectomy specimens.
Qian J; Bostwick DG
Pathol Res Pract; 1995 Sep; 191(9):860-7. PubMed ID: 8606866
[TBL] [Abstract][Full Text] [Related]
5. Relationship between atypical adenomatous hyperplasia (AAH), prostatic intraepithelial neoplasia (PIN) and prostatic adenocarcinoma.
Helpap B; Bonkhoff H; Cockett A; Montironi R; Troncoso P; Waters D; Bostwick D
Pathologica; 1997 Jun; 89(3):288-300. PubMed ID: 9270265
[TBL] [Abstract][Full Text] [Related]
6. A unifying hypothesis that links benign prostatic hyperplasia and prostatic intraepithelial neoplasia with prostate cancer. Invited comments.
Harvey H
Pathol Res Pract; 1995 Sep; 191(9):924-34. PubMed ID: 8606875
[TBL] [Abstract][Full Text] [Related]
7. The significance of atypical adenomatous hyperplasia and prostatic intraepithelial neoplasia for the development of prostate carcinoma. An update.
Helpap BG; Bostwick DG; Montironi R
Virchows Arch; 1995; 426(5):425-34. PubMed ID: 7543337
[TBL] [Abstract][Full Text] [Related]
8. [Premalignant and benign lesions in nodules of adenomatous hyperplasia].
Miján Ortiz JL; Fernández Rodríguez A; Fernández Ruiz PL; de la Fuente Serrano A; Nogales Fernández F; Zuluaga Gómez A
Arch Esp Urol; 1996 Sep; 49(7):684-7. PubMed ID: 9020004
[TBL] [Abstract][Full Text] [Related]
9. Premalignant lesions of prostate and their association with nodular hyperplasia and carcinoma prostate.
Rekhi B; Jaswal TS; Arora B
Indian J Cancer; 2004; 41(2):60-5. PubMed ID: 15318010
[TBL] [Abstract][Full Text] [Related]
10. Prostatic intraepithelial neoplasia in TURP specimens and subsequent prostate cancer.
Meyer F; Têtu B; Bairati I; Lacombe L; Fradet Y
Can J Urol; 2006 Oct; 13(5):3255-60. PubMed ID: 17076947
[TBL] [Abstract][Full Text] [Related]
11. Working standards in prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia.
Algaba F; Epstein JI; Fabus G; Helpap B; Nagle RB; Polito M
Pathol Res Pract; 1995 Sep; 191(9):836-7. PubMed ID: 8606861
[TBL] [Abstract][Full Text] [Related]
12. Role of AgNOR count and its correlation with serum PSA levels in prostatic lesions.
Goel T; Garg S
Urol Int; 2009; 82(3):286-90. PubMed ID: 19440015
[TBL] [Abstract][Full Text] [Related]
13. Expression of androgen receptor and growth factors in premalignant lesions of the prostate.
Harper ME; Glynne-Jones E; Goddard L; Mathews P; Nicholson RI
J Pathol; 1998 Oct; 186(2):169-77. PubMed ID: 9924433
[TBL] [Abstract][Full Text] [Related]
14. Silver-stained nucleolar organizer regions in the differentiation of prostatic hyperplasia, intraepithelial neoplasia, and adenocarcinoma.
Cheville JC; Clamon GH; Robinson RA
Mod Pathol; 1990 Sep; 3(5):596-8. PubMed ID: 1700418
[TBL] [Abstract][Full Text] [Related]
15. Argyrophilic nucleolar organizer regions in atypical adenomatous hyperplasias, prostatic intraepithelial neoplasias and prostatic neoplasms.
Mukherjee J; Misra V; Gupta SC; Gupta AK; Tandon SP
Urol Int; 1997; 58(2):75-9. PubMed ID: 9096266
[TBL] [Abstract][Full Text] [Related]
16. Production of serum-free and total prostate-specific antigen due to prostatic intraepithelial neoplasia.
Minardi D; Galosi AB; Dell'Atti L; Hanitzsch H; Mario P; Muzzonigro G
Scand J Urol Nephrol; 2002; 36(5):323-9. PubMed ID: 12487735
[TBL] [Abstract][Full Text] [Related]
17. [AGNOR analyses of prostate carcinomas of high and malignancy].
Helpap B; Riede C
Verh Dtsch Ges Pathol; 1993; 77():93-7. PubMed ID: 7511310
[TBL] [Abstract][Full Text] [Related]
18. Free and total serum PSA values in patients with prostatic intraepithelial neoplasia (PIN), prostate cancer and BPH. Is F/T PSA a potential probe for dormant and manifest cancer?
Tarle M; Kraljić I
Anticancer Res; 1997; 17(3A):1531-4. PubMed ID: 9179191
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic limits in precursor lesions of prostatic cancer.
Algaba F; Trias I
Eur Urol; 1996; 30(2):212-21. PubMed ID: 8875203
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of high-grade prostatic intraepithelial neoplasia in transurethral resection specimens.
Pacelli A; Bostwick DG
Urology; 1997 Sep; 50(3):355-9. PubMed ID: 9301697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
